What is the marketed brand name of omalizumab?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Brand Name of Omalizumab

The brand name of omalizumab is Xolair. 1, 2

Xolair is manufactured by Genentech, Inc. (a member of the Roche Group) and jointly marketed by Genentech USA, Inc. and Novartis Pharmaceuticals Corporation. 2 The medication is available as a subcutaneous injection in multiple formulations including prefilled syringes, autoinjectors, and vials for reconstitution. 2

The drug is FDA-approved and marketed under the Xolair brand name for multiple indications including allergic asthma, chronic rhinosinusitis with nasal polyps, chronic spontaneous urticaria, and IgE-mediated food allergy. 2

References

Related Questions

What are the common and serious side effects of Xolair (omalizumab) and how should patients be monitored?
What are the indications, dosing regimen, administration guidelines, contraindications, adverse effects, and monitoring recommendations for omalizumab (Xolair)?
Is there a generic version of Xolair (omalizumab)?
Can Xolair (omalizumab) be used to treat patients with mast cell activation in a chronic flare and what is its effectiveness?
What is the recommended primary treatment for bullous pemphigoid in an elderly patient with extensive disease?
What are the current guideline-recommended management strategies for hypertension in patients with chronic kidney disease (CKD), both with diabetes mellitus (DM) and without diabetes?
Is a white blood cell count of 16.3 × 10⁹/L with an absolute neutrophil count of 12.5 × 10⁹/L indicative of a viral infection?
Is there any relationship between systemic lupus erythematosus (SLE) and Tetralogy of Fallot (TOF) in a 21-year-old patient?
In a 21‑year‑old patient with systemic lupus erythematosus (SLE) and Tetralogy of Fallot, is dengue fever a manifestation of SLE or merely a trigger for an SLE flare?
What are mast cell disorders, their types, diagnostic criteria, and treatment options?
What are the differential diagnoses for a 31‑year‑old male with persistent spastic dysarthria and spastic gait after titubation resolved with treatment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.